Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. has updated on its share buyback program initiated in April 2025, aimed at acquiring shares for stock option and performance share plans for management. Between May 26 and May 30, 2025, Recordati purchased 76,378 shares, holding 1.604% of its share capital by the end of May, reflecting its strategic focus on incentivizing management and aligning with shareholder interests.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR55.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, and operates in about 150 countries across the EMEA, Americas, and APAC regions, employing over 4,580 people.
Average Trading Volume: 405,212
Technical Sentiment Signal: Buy
Current Market Cap: €10.97B
Learn more about REC stock on TipRanks’ Stock Analysis page.